权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Towards an Integrated Understanding of Neurotransmitter Dysfunction in Schizophrenia: a Multimodal MRI Study

全面了解精神分裂症神经递质功能障碍：多模态 MRI 研究

基本信息

批准号：
10462595
负责人：
Jodi Jay Weinstein
金额：
$ 22.76万
依托单位：
STATE UNIVERSITY NEW YORK STONY BROOK
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-07-09 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10462595
关键词：
Age Anatomy Animal Model Anterior Antipsychotic Agents Attention Back Base of the Brain Biological Blood Brain Cerebrum Clinical Corpus striatum structure Data Development Disease Dopamine Ensure Environment Equilibrium Ethnic Origin Fostering Functional disorder Funding Glutamates Glutamine Goals Hippocampus (Brain)Human Hyperactivity Imaging Techniques Individual Interneuron function Interneurons Lead Link Literature Longevity Magnetic Resonance Magnetic Resonance Imaging Magnetic Resonance Spectroscopy Measures Medical Methodology Methods Methylazoxymethanol Acetate Midbrain structure Modeling Molecular Multimodal Imaging Neurobiology Neurons Neuropsychology Neurosciences Neurotransmitters Output Participant Parvalbumins Pathology Patients Pharmaceutical Preparations Physicians Physiologic pulse Positron-Emission Tomography Prevention Protocols documentation Proxy Psychotic Disorders Research Research Personnel Research Training Resources Rodent Rodent Model Schizophrenia Scientist Severities Signal Transduction Socioeconomic Status Substantia nigra structure Symptoms System Testing Tobacco use Training Training Programs United States National Institutes of Health Ventral Striatum clinical high risk for psychosis contrast enhanced dopamine system dopaminergic neuron drug development gamma-Aminobutyric Acid imaging modality imaging study in vivo in vivo imaging indexing individual patient innovation magnetic field multimodality neural circuit neurochemistry neuroimaging neuromelanin new therapeutic target novel pre-clinical prenatal recruit relating to nervous system responsible research conduct sex therapeutic evaluation

项目摘要

PROJECT SUMMARY / ABSTRACT Schizophrenia is among the most severe and burdensome medical conditions worldwide, yet the brain alterations that lead to the symptoms of schizophrenia remain unknown. This K23 application presents a research and training program that will support the applicant on a path towards becoming an NIH-‐funded independent investigator focused on understanding the neurobiology of schizophrenia and related psychotic disorders. The activities in this application build on the candidate’s prior training and are set in a resource-‐rich environment that will foster her development of expertise in 1) application of MRS and advanced MRI neuroimaging methodologies; 2) physician-‐scientist approaches to studying pathophysiology in patients with schizophrenia; 3) neurocircuitry and systems neuroscience perspectives on hippocampus pathology in psychotic disorders; and 4) responsible conduct of research. The overarching goal of the research to be carried out in this application is to take findings from animal models of schizophrenia, which were motivated by original research in patients with the disorder, back to the clinical setting in order to determine whether the brain circuit alterations observed in the animal models are observable in human patients. Specifically, findings in the prenatal methylazoxymethanol acetate (MAM) rodent model, which was developed to model the alterations in dopamine function seen in patients with schizophrenia, suggest hyperactivity of the ventral (anterior) hippocampus may increase its glutamatergic output to the ventral striatum and lead, via ventral pallidal and other GABAergic projections to the ventral midbrain, to disinhibited firing of dopamine neurons. In addition, a convergence of several post mortem and in vivo imaging findings in patients suggests that abnormal GABAergic activity in the hippocampus may further compound hippocampal glutamatergic overdrive. This project will directly test the relationships among these neurochemical alterations in individual medication-‐free patients with schizophrenia using sophisticated magnetic resonance imaging methods. If this non-‐invasive, multimodal imaging paradigm provides evidence to relate hippocampal GABA and glutamate abnormalities to dopamine system dysfunction in patients with schizophrenia, it would have important implications for our understanding of the brain bases of schizophrenia, and would generate a novel multimodal imaging paradigm for testing new molecular, anatomical, and circuit-‐modulating targets for treatment of this devastating illness.

项目摘要/摘要